3vrn: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3vrn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vrn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3vrn RCSB], [http://www.ebi.ac.uk/pdbsum/3vrn PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3vrn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vrn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3vrn RCSB], [http://www.ebi.ac.uk/pdbsum/3vrn PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[[http://www.uniprot.org/uniprot/CBLC_HUMAN CBLC_HUMAN]] Regulator of EGFR mediated signal transduction. | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == |
Revision as of 13:08, 25 December 2014
Crystal structure of the tyrosine kinase binding domain of Cbl-cCrystal structure of the tyrosine kinase binding domain of Cbl-c
Structural highlights
Function[CBLC_HUMAN] Regulator of EGFR mediated signal transduction. Publication Abstract from PubMedThrough their ubiquitin ligase activity, Cbl-family proteins suppress signalling mediated by protein-tyrosine kinases (PTKs), but can also function as adaptor proteins to positively regulate signalling. The tyrosine kinase binding (TKB) domain of this family is critical for binding with tyrosine-phosphorylated target proteins. Here, we analysed the crystal structure of the TKB domain of Cbl-c/Cbl-3 (Cbl-c TKB), which is a distinct member of the mammalian Cbl-family. In comparison with Cbl TKB, Cbl-c TKB showed restricted structural flexibility upon phosphopeptide binding. A mutation in Cbl-c TKB augmenting this flexibility enhanced its binding to target phosphoproteins. These results suggest that proteins, post-translational modifications or mutations that alter structural flexibility of the TKB domain of Cbl-family proteins could regulate their binding to target phosphoproteins and thereby, affect PTK-mediated signalling. Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.,Takeshita K, Tezuka T, Isozaki Y, Yamashita E, Suzuki M, Kim M, Yamanashi Y, Yamamoto T, Nakagawa A J Biochem. 2012 Nov;152(5):487-95. doi: 10.1093/jb/mvs085. Epub 2012 Aug 9. PMID:22888118[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|